Clinical trial
Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity
NCT02285374
Study timeline
Study start (unknown)2014-11-01Date precision: month
Registry last updated2014-11-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIVunresolved
Interventions
Sponsors & collaborators
St Stephens Aids Trustlead sponsor
ViiV Healthcarecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02285374 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.